NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
49
UTHR Quote, Financials, Valuation and Earnings
Last price:
$362.13
Seasonality move
:
6.42%
Day range:
$357.99 - $363.90
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
15.79x
P/S ratio:
6.38x
P/B ratio:
2.63x
Volume:
925.6K
Avg. volume:
333.7K
1-year change:
59.45%
Market cap:
$16.1B
Revenue:
$2.3B
EPS (TTM):
$22.77
UTHR Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for United Therapeutics shares anticipate an average target of $335.33, ranging from a low estimate of $221.00 to a high estimate of $400.00. This average target implies a growth of 9.5% compared to the current stock price of $359.58.
Consensus Price Target
$335.33
Highest Price Target
$400.00
Lowest Price Target
$221.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 7 | 7 |
| Hold | 4 | 5 | 6 |
| Sell | 0 | 1 | 0 |
| Consensus | Buy | Buy | Buy |
UTHR Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 4.46% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 10.25% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.77% over the past day.
